CLARITIN Drug Profile, 2019 - Patents, Clinical Trials, Drug Prices, Annual Sales Revenues and Raw API Sources - ResearchAndMarkets.com

The "CLARITIN Drug Profile, 2019" report has been added to ResearchAndMarkets.com's offering.

CLARITIN Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs. The report focuses on CLARITIN and covers the following critical aspects of this drug:

• United States patents
• Expired United States patents
• District Court patent litigation
• European supplementary protection certificates (SPCs)
• Clinical trials
• Annual sales revenues
• Finished product suppliers
• Raw active pharmaceutical ingredient (API) sources

Topics Covered

• Profile for CLARITIN
• US Patents
• Expired US Patents
• US District Court Litigation
• International (ex US) Patents
• Supplementary Protection Certificates
• Clinical Trials
• Annual Sales Revenues
• Finished Product Suppliers
• Bulk API Sources

Companies Featured

• Bayer Healthcare
  
• Lil' Drug Store Products
• Sigma-Aldrich
• Molport
• Abi Chem
• Vitas-M Laboratory
• Forechem
• Chemmol
• Abblis Chemicals
• Biochempartner
• Medchemexpress Mce
• Abachemscene
• Mcule
• Synblock Inc
• Act Chemical
• An Pharmatech
• Syntree
• Founder Pharma
• Labseeker
• Avachem Scientific
• Bide Pharmatech Ltd.
• Tocris Bioscience
• Biosynth
• Oxchem Corporation
• Clearsynth
• Phion Ltd
• Enovation Chemicals
• Abovchem Llc
• LGC Standards
• Activate Scientific
• Ochem
• King Scientific
• 001Chemical
• Ambeed
• and many more...
  

For more information about this report visit https://www.researchandmarkets.com/research/wn2vml/claritin_drug?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190114005404/en/